AstraZeneca gets nod to import Lokelma for treating high potassium in blood

The pharma giant has received the CDSCO nod to import sodium zirconium cyclosilicate powder for oral suspension (Lokelma) in 5 g and 10 g formulations. Shares of Astrazeneca Pharma India Ltd ended at ₹7,458.95, up by ₹117.65, or 1.60%, on the BSE.